Biomedical investment growing in Cleveland, Midwest

Canvasses featuring the faces of children who have rare genetic diseases adorn the entrance wall at Abeona Therapeutics.

From its office in the MidTown Tech Park in Cleveland’s Health-Tech Corridor, Abeona’s 50 employees work to find cures for diseases such as Epidermolysis Bullosa and Sanfilippo Syndrome, which affect 1 in 20,000 and 1 in 70,000 babies born, respectively. They’re completing clinical trials now and hope to commercialize their treatments soon.

Click here to read the complete article. Story excerpt provided by The Plain Dealer. Written by Ginger Christ. Originally published June 24, 2018.